Page last updated: 2024-08-26

phorbolol myristate acetate and Leucocythaemia

phorbolol myristate acetate has been researched along with Leucocythaemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gabrilovac, J; Martin-Kleiner, I; Svoboda-Beusan, I	1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Leucocythaemia

Article	Year
PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cells. Immunopharmacology and immunotoxicology, 2006, Volume: 28, Issue:3 Topics: Antibiotics, Antineoplastic; Antigens, CD20; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Formazans; Humans; Immunoglobulin mu-Chains; Leukemia; Neprilysin; Syndecan-1; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Time Factors; Tretinoin	2006

Article

Year

PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cells.

Immunopharmacology and immunotoxicology, 2006, Volume: 28, Issue:3

Topics: Antibiotics, Antineoplastic; Antigens, CD20; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Formazans; Humans; Immunoglobulin mu-Chains; Leukemia; Neprilysin; Syndecan-1; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Time Factors; Tretinoin

2006